Neuraptive Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersChesterbrook, PA
SAM.gov UEIYJKYRWQCB331
Neuraptive develops novel therapeutics and medical products for peripheral nerve injuries. The company's technology includes PEG-FUSION, a fusion system for repairing severed peripheral nerves licensed from the University of Texas at Austin; a specialized drug delivery device for topical administration of active agents directly on the nerve; and nerve-specific microsurgical instruments. Neuraptive serves physicians and patients impacted by peripheral nerve injuries and peripheral nerve reconstruction procedures.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neuraptive Therapeutics, INC. | Chesterbrook | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.